P-106 COVID-19 PRESENTATION AND OUTCOMES IN 33 PATIENTS WITH AUTOIMMUNE HEPATITIS

BACKGROUND AND AIMS: Clinical course of Covid-19 is not yet established in autoimmune hepatitis (AIH). About 25% of our 400 AIH-outpatients from various states in Brazil are using hydrochloroquine (HCQ) for maintenance or treatment with corticosteroids and immunosuppressants (IS). The aim is to desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadini Margon, Julia, Raddatz Reis Vilela, Monique, Damasio Moutinho, Bruna, Rodrigues de Figueiredo, Sabrina, Mitiko Deguti, Marta, Benedita Terrabuio, Débora Raquel, Rachid Cançado, Eduardo Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468375/
http://dx.doi.org/10.1016/j.aohep.2021.100466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468375/
http://dx.doi.org/10.1016/j.aohep.2021.100466

Ejemplares similares